Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

FARALLON CAPITAL MANAGEMENT LLC 13F Holdings -- Portfolio & Top Positions (2026-03-31)

FARALLON CAPITAL MANAGEMENT LLC (CIK 909661) reported $17.54B across 167 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: SPY ($1.50B, 8.53%), RVMD ($1.32B, 7.54%), AMZN ($878.6M, 5.01%), MSFT ($868.0M, 4.95%), AON ($811.0M, 4.62%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1SPYSTATE STR SPDR S&P 500 ETF T$1.50B8.53%2.3MNew
2RVMDREVOLUTION MEDICINES INC$1.32B7.54%13.6MTrimmed
3AMZNAMAZON COM INC$878.6M5.01%4.2MTrimmed
4MSFTMICROSOFT CORP$868.0M4.95%2.3MAdded
5AONAON PLC$811.0M4.62%2.5MTrimmed
6BBIOBRIDGEBIO PHARMA INC$695.5M3.96%9.4MAdded
7EWSCINVESCO EXCHANGE TRADED FD T$690.9M3.94%3.6MNew
8PTGXPROTAGONIST THERAPEUTICS INC$669.2M3.81%6.3MAdded
9NTRANATERA INC$641.4M3.66%3.2MTrimmed
10EXELEXELIXIS INC$562.3M3.21%13.1MTrimmed
11AVGOBROADCOM INC$550.8M3.14%1.8MAdded
12UNHUNITEDHEALTH GROUP INC$492.9M2.81%1.8MAdded
13SNPSSYNOPSYS INC$481.0M2.74%1.2MAdded
14BSXBOSTON SCIENTIFIC CORP$468.8M2.67%7.5MAdded
15TMOTHERMO FISHER SCIENTIFIC INC$433.3M2.47%881,485Added
16KKRKKR & CO INC$432.1M2.46%4.7MAdded
17LNTHLANTHEUS HLDGS INC$423.5M2.41%5.6MAdded
18WABWABTEC$402.2M2.29%1.6MTrimmed
19SCHWSCHWAB CHARLES CORP$371.8M2.12%4.0MAdded
20LQDALIQUIDIA CORPORATION$326.7M1.86%8.7MHold
21CRNXCRINETICS PHARMACEUTICALS IN$302.8M1.73%8.3MAdded
22GOOGALPHABET INC$285.8M1.63%996,231Added
23ROIVROIVANT SCIENCES LTD$268.0M1.53%9.7MAdded
24VVISA INC$254.1M1.45%840,710Added
25ARMKARAMARK$248.7M1.42%6.1MTrimmed

Source: SEC Form 13F filings · as of 2026-03-31